Key result
Stent implantation for CHD achieves ~96% procedural success and high survival to discharge.
Why the study?
Stent implantation for vascular stenosis associated with congenital heart diseases is commonly performed off-label in Japan because no stent is officially approved for any congenital heart disease.
Observational (n=391)
Yes
Off-label stent implantation for congenital heart diseases in Japan demonstrates high procedural success and acceptable safety, supporting the need for official device approval.
Answers are grounded in this paper and cite their sources.
May support off-label stent use in congenital heart disease; leaves open the need for dedicated device approval and randomized data.
BACKGROUND: Stent implantation for vascular stenosis associated with congenital heart diseases is commonly performed as an off-label procedure in Japan because there is no officially approved stent for any congenital heart disease. METHODS AND RESULTS: We analyzed data from the Japanese Society of Congenital Interventional Cardiology Registry collected from January 2016 to December 2018. Patients who underwent stent implantation were enrolled in the present analysis. During the study period, there were 470 procedures, 443 sessions, and 391 cases. Of 443 sessions, 427 (96.4%) succeeded procedurally. There were no differences in the procedural success rates among age groups. In all, 416 sessions (367 patients; 94%) resulted in survival to 30 days after catheter intervention. Of 392 admissions, 357 patients (91%) survived to discharge. Only 4 deaths were directly related to stent implantation. Some in-hospital complications were observed during 55 of 443 sessions. Both hospital deaths and serious complications were significantly more frequent in the group with various preoperative risk factors. CONCLUSIONS: Although not officially approved for congenital heart diseases in Japan, stent implantation in congenital heart diseases has been widely and routinely performed for many years with safety and efficacy. The aim of stenting was variable and broad because of many different applications and morphological variations. These data may facilitate approval of such an important device in Japan.
No takes yet. Share an insight, caveat, or question.
A 2021 study conducted an observational in Congenital heart disease with vascular stenosis (n=391). Stent implantation was evaluated on Procedural success rate. In a nationwide Japanese registry, stent implantation for congenital heart disease achieved a procedural success rate of 96.4%, with 91% of patients surviving to hospital discharge.
Synapse has enriched 10 related papers. Consider them for comparative context: